Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Neurosci ; 27(3): 212-222, 2024 Mar.
Article in English | MEDLINE | ID: mdl-36809120

ABSTRACT

ABSTRACTThe brain aging process triggers cognitive function impairment, such as memory loss and compromised quality of life. Cognitive impairment is based on bioenergetic status, with reduced glucose uptake and metabolism in aged brains. Anaplerotic substrates are reported to promote mitochondrial ATP generation, having been tested in clinical trials for the treatment of neurological disorders and metabolic diseases.Objectives and Methods: To assess whether the improvement in oxidative capacity ameliorates cognitive function in adults (12 weeks), and aged (22-month-old) C57/6BJ mice, they received (1) a ketogenic diet, (2) a ketogenic diet supplemented with the anaplerotic substance, triheptanoin, or (3) a control diet for 12 weeks. Spontaneous alternation and time spent in a previously closed arm in the Y-maze test and time interacting with an unknown object in the novel object recognition test (NORT) were used to evaluate working memory. Acetylcholinesterase (AChE) activity in the prefrontal lobe, brain left hemisphere, and cerebellum was also evaluated. Glucose transporter 3 (GLUT3) expression in the prefrontal lobe was analyzed by western blotting.Results: The ketogenic diet (KD) reduced spontaneous alternation in aged mice, leading to lower AChE activity in the aged prefrontal lobe and cerebellum, and in the parieto-temporal-occipital lobe of adult mice. Furthermore, KD decreased GLUT3 protein expression in the frontal lobe of the adults.Discussion: Supplementation of KD with triheptanoin prevented memory impairment and showed similar values of AChE activity and GLUT3 expression compared to the controls. Our data suggest that triheptanoin has a potential role in the bioenergetic capacity of the brain, improving cognitive function.


Subject(s)
Acetylcholinesterase , Quality of Life , Mice , Animals , Glucose Transporter Type 3/metabolism , Acetylcholinesterase/metabolism , Triglycerides , Brain/metabolism , Cognition
2.
Brain Res ; 1615: 106-115, 2015 Jul 30.
Article in English | MEDLINE | ID: mdl-25916576

ABSTRACT

Retinocollicular connections form precise topographical maps that are normally completed through the selective elimination of misplaced axons and the stabilization of topographically ordered axon terminals during early development. Omega-3 fatty acids, acquired exclusively through the diet, and its main metabolite, docosahexaenoic acid (DHA), are involved in brain development and synaptic maturation. We have previously shown that the nutritional restriction of omega-3/DHA results in abnormal retinocollicular topographical fine-tuning. Therefore, we studied the role of omega-3 fatty acids nutritional supplementation and the developmental time windows during which this postnatal supplementation would restore normal topographical maps in the visual system. Female rats and their litters were chronically fed with either control (soy oil) or restricted omega-3 (coconut oil) diets. Fish oil supplementation was introduced between either postnatal day (PND) 7-13, PND7-28 or PND21-42. At PND13, PND28 or PND42, animals received an anterograde eye injection of a neuronal tracer to visualize retinocollicular axons. Confirming previous observations we found that an omega-3/DHA deficiency resulted in an abnormally high innervation density of retinal axons at the visual layers of the superior colliculus (SC). Although a short-term fish oil supplementation between PND7-13 could not restore normal retinocollicular topography, an extended treatment between PND7-28 completely recovered normal innervation densities of retinotectal axons. However, a late onset supplementation protocol, between PND28-42, was no longer effective in the restoration of the abnormal topographical pattern induced by an early omega-3 nutritional malnutrition. The results suggest a critical period for omega3/DHA dietary intake for the proper development of visual topographical maps.


Subject(s)
Fatty Acids, Omega-3/administration & dosage , Retina/growth & development , Superior Colliculi/growth & development , Visual Pathways/growth & development , Animals , Dietary Supplements , Docosahexaenoic Acids/administration & dosage , Female , Rats , Retina/cytology , Superior Colliculi/cytology , Time Factors
3.
Neurochem Res ; 35(5): 820-9, 2010 May.
Article in English | MEDLINE | ID: mdl-20180018

ABSTRACT

Reduced neurotrophic support is one possible cause for retinal ganglion cells dying in glaucoma. Experiments were designed to investigate the effect of EP2 receptor agonist butaprost on transformed retinal ganglion (RGC-5) cells where reduced neurotrophic support was simulated by serum withdrawal. Cultures were analysed for cell viability, flow cytometry, reactive oxygen species and apoptosis. Western blot and immunohistochemistry were used to provide information for the occurrence of PGE(2) receptor-types. We demonstrated the existence of all four types of PGE(2) receptors in RGC-5 cells and exposure of cultures to butaprost resulted in an elevation of cAMP. Serum deprivation induced RGC-5 cell death was significantly attenuated by butaprost as well as by rolipram and forskolin where intracellular cAMP levels were increased. These data are of value in relation to the possible use of EP2 receptor agonists to reduce both elevated intraocular pressure and retinal ganglion cell death as occurs in glaucoma.


Subject(s)
Receptors, Prostaglandin E/metabolism , Retinal Ganglion Cells/metabolism , Alprostadil/analogs & derivatives , Alprostadil/pharmacology , Animals , Apoptosis/drug effects , Cell Line , Cell Survival/drug effects , Culture Media, Serum-Free/pharmacology , Rats , Reactive Oxygen Species/metabolism , Receptors, Prostaglandin E/agonists , Receptors, Prostaglandin E, EP2 Subtype , Retinal Ganglion Cells/drug effects
4.
Brain Res Bull ; 64(5): 395-408, 2005 Jan 15.
Article in English | MEDLINE | ID: mdl-15607827

ABSTRACT

We investigated in young rats the effects of malnutrition on the main structures of the circadian timing system: retina, hypothalamic suprachiasmatic nuclei (SCN), thalamic intergeniculate leaflet, retinohypothalamic- and geniculohypothalamic tracts. Control rats were born from mothers fed a commercial diet since gestation, and malnourished rats from mothers fed a multideficient diet since gestation (GLA group) or lactation (LA group). After weaning, pups received the same diet as their mothers, and were analysed at postnatal days 27, 30-33 and 60-63. Brain sections were processed to visualise in the SCN neuropeptide Y immunoreactivity and terminal labeling after intraocular tracer injections. Nissl staining was used to assess cytoarchitectonic boundaries of the SCN and cell features in retinal whole mounts. Cell counts, morphometric and densitometric analysis were performed. Compared with controls, the total retinal surface was reduced and the topographical distribution of retinal ganglion cells was altered in malnourished rats, with changes in their density. Alterations were also detected in the SCN dimensions in the GLA and LA groups at one and two postnatal months, as well as in the SCN portion occupied by the retinal input in the GLA group at days 30-33, but not in the NPY-containing geniculohypothalamic tract. The present data point to subtle changes, with a low and differential vulnerability to early malnutrition, of structures involved in circadian timing regulation. Furthermore, the present findings suggest that the altered circadian rhythmicity previously documented in malnourished rats cannot be ascribed to impaired development of the retino- and geniculohypothalamic projections to the SCN.


Subject(s)
Brain/pathology , Geniculate Bodies/pathology , Malnutrition/pathology , Retina/pathology , Suprachiasmatic Nucleus/pathology , Age Factors , Animals , Animals, Newborn , Body Weight/physiology , Brain/cytology , Brain/growth & development , Brain/metabolism , Cell Count/methods , Cell Size , Female , Geniculate Bodies/anatomy & histology , Geniculate Bodies/growth & development , Geniculate Bodies/metabolism , Immunohistochemistry/methods , Lactation , Male , Neural Pathways/growth & development , Neural Pathways/pathology , Neurons/metabolism , Neurons/pathology , Neuropeptide Y/metabolism , Organ Size/physiology , Rats , Rats, Wistar , Retina/cytology , Retina/growth & development , Retina/metabolism , Sex Factors , Staining and Labeling/methods , Suprachiasmatic Nucleus/growth & development , Suprachiasmatic Nucleus/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...